Cargando…
Recent advances and limitations of mTOR inhibitors in the treatment of cancer
The PI3K-Akt-mechanistic (formerly mammalian) target of the rapamycin (mTOR) signaling pathway is important in a variety of biological activities, including cellular proliferation, survival, metabolism, autophagy, and immunity. Abnormal PI3K-Akt-mTOR signalling activation can promote transformation...
Autores principales: | Ali, Eunus S., Mitra, Kangkana, Akter, Shamima, Ramproshad, Sarker, Mondal, Banani, Khan, Ishaq N., Islam, Muhammad Torequl, Sharifi-Rad, Javad, Calina, Daniela, Cho, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476305/ https://www.ncbi.nlm.nih.gov/pubmed/36109789 http://dx.doi.org/10.1186/s12935-022-02706-8 |
Ejemplares similares
-
Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview
por: Ali, Eunus S., et al.
Publicado: (2022) -
TRPM2-mediated Ca(2+) signaling as a potential therapeutic target in cancer treatment: an updated review of its role in survival and proliferation of cancer cells
por: Ali, Eunus S., et al.
Publicado: (2023) -
Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
por: Calina, Daniela, et al.
Publicado: (2020) -
Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
por: Sarkar, Chandan, et al.
Publicado: (2020) -
A Perspective on Emerging Therapeutic Interventions for COVID-19
por: Torequl Islam, Muhammad, et al.
Publicado: (2020)